CD135 (FLT3) Antibody, anti-mouse, REAfinity™
Synonyms: FLT3, FLK-2, Ly72, wmfl, Flt3/Flk2, STK-1
RECOMBINANT
Bioz Star92/100 Bioz rating
4 Citations2 Images
Clone:
REA779 | A2F10
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD135 (FLT3) Antibody, anti-mouse, REAfinity™

Flow cytometry applications
APC
Biotin
PE
PE-Vio 770
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-111-036, 130-111-152
Description:
Bone marrow cells from C57BL/6 mice were stained with CD135 (FLT3) antibodies or the corresponding REA Control antibodies (left image) as well as with CD117 antibodies. Lineage– cells were pre-gated for the analysis. Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence or 4',6-diamidino-2-phenylindole (DAPI) fluorescence, as in the case of tandem conjugates.

Application imageView details view details

Application imageView details view details
Specifications for CD135 (FLT3) Antibody, anti-mouse, REAfinity™
Overview

Clone REA779 recognizes the mouse CD135 antigen, a 150 kDa surface protein Fms-like tyrosine kinase receptor 3 (FLT3), also known as FLK-2. CD135 has functional and structural homology to the class III–receptor tyrosine kinases that include the M-CSF-, KIT-, and PDGF-receptors. The receptor is expressed on progenitor cells in adult bone marrow, thymus, brain, testis, and placenta. All hematopoietic cells develop from CD135 negative hematopoietic stem cells (HSCs) through CD135 positive progenitor cells. In synergy with other growth factors like G-CSF, GM-CSF, SCF, and IL-3, ligation of CD135 with FLT3 ligand promotes the proliferation and differentiation of primitive hematopoietic stem cells. As a result early B cell lineage differentiation as well as expansion of monocytes and immature dendritic cells are stimulated.

Additional information: Clone REA779 displays negligible binding to Fc receptors.

Alternative names

FLT3, FLK-2, Ly72, wmfl, Flt3/Flk2, STK-1

Detailed product information

Technical specifications

Clone
REA779
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
CD135 (FLT3)
Molecular mass of antigen [kDa]
110
Distribution of antigen
B cells, stem cells, hematopoietic stem and progenitor cells, spleen, bone marrow, brain, lung
Entrez Gene ID
RRID
AB_2654958, AB_2654952, AB_2654951, AB_2654956, AB_2654953, AB_2654957, AB_2654955, AB_2654954

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD135 (FLT3) Antibody, anti-mouse, REAfinity™
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?